CIRCULATING HU PROTEIN ASSESSMENT FOR ARRHYTHMIC RISK STRATIFICATION IN HEART FAILURE PATIENTS

Cardiac arrhythmias associated with heart failure (HF) cause a significant number of deaths worldwide, and the implantable cardioverter defibrillator (ICD) has emerged as an important treatment option for patients at risk of sudden cardiac death. Nevertheless, current risk stratification is